Chat real-time with other investors about this AEND news release, by
clicking this link: http://www.stockwire.com/AEND
To view in-depth research, click the following link:
http://www.stockwire.com/detailed/analysis.php?company=AEND
American Ent Dev Corp (Pink Sheets: AEND)
HAVOC Third Quarter Sales Results
HOUSTON, Oct 18, 2007 HAVOC gained several new marketing and distribution relationships in the 3rd quarter that have increased sales significantly.
"As we grow our traction continues to increase," noted Aylin Gormus, VP of Operations. "We continue to grow relationships with high profile corporations, night clubs, Casinos and added a strong distribution agreement with Natural Water Company of Oklahoma," she said.
"Our management team is driving hard to continue growth through the end of this year and beyond. We are very proud of our management team; they are an example of the professionalism that we strive for at HAVOC," stated CK Williams CEO. "We think we have only scratched the surface this year and expect the years of management team experience to pay off even more as we move into nationwide distribution next year," he added. "When combined with our great tasting energy drink and our dominant marketing relationships, we feel like we are strapped to a rocket," he concluded.
HAVOC is owned by American Enterprise Development Corporation Drink. HAVOC co-brands its popular energy drink with major sports franchises, college universities and major entertainment venues. More information is available at our Web site: http://www.havocenergy.com. HAVOC(TM) competes in the rapidly growing energy drink sector against Hanson Natural Corp., HAVOC Distribution, Inc. is based in Dallas, Texas. It develops, manufactures and distributes energy drink products through strong affiliations with collegiate universities and conferences, professional sports franchises and corporate alliances. American Enterprise Development is represented by Sports Media, Inc
----------------------------------------------------------
Chat real-time with other investors about this DPBM news release, by
clicking this link: http://www.stockwire.com/DPBM
To view in-depth research, click the following link:
http://www.stockwire.com/detailed/analysis.php?company=DPBM
Deep Blue Marine Inc (Pink Sheets: DPBM)
Deep Blue Marine, Inc. Buys Back Stock
SALT LAKE CITY, UT, Oct 18, 2007 Deep Blue Marine, Inc. (PINKSHEETS: DPBM) is pleased to announce that the company, Deep Blue Marine, Inc., has purchased back the shares issued to Ed and Joe Krajewski and the shares have been returned to the treasury.
----------------------------------------------------------
Chat real-time with other investors about this ONCO news release, by
clicking this link: http://www.stockwire.com/ONCO
To view in-depth research, click the following link:
http://www.stockwire.com/detailed/analysis.php?company=ONCO
Oncology Med Inc Del (Pink Sheet: ONCO)
Oncology Med Expects Revenues to Increase 20% Annually as a Result of Its New Multiple Year Contract With Humility of Mary Health Partners
PITTSBURGH, PA, Oct 18, 2007 Oncology Med, Inc. (PINKSHEETS: ONCO), a Pittsburgh-based cancer treatment solutions group, announced today that as a result of the new multiple year exclusive contract with Humility of Mary Health Partners, a division of Catholic Healthcare Partners, the largest health system in Ohio and the seventh largest not-for-profit health system in the United States, the Company expects an annual revenue increase of 20% over its current revenue run rate.
According to William Walker, Ph.D., Oncology Med's CEO and founder, "This new contract is one of the many that we hope to announce to our investors and other interested parties over the next several quarters centered around one of our new turnkey programs for cancer treatment. We are aggressively going after new clients in order to increase our revenues and profit margins." About Oncology Med, Inc.
Oncology Med is a public company engaged in the fulfillment of services related to the treatment of various cancers. It currently provides analysis and design of radiation treatment plans in order for radiation oncologists to administer radiation treatments to cancer patients. Current services facilitate radiation treatment programs ranging from external beam radiation to more advanced radiation treatment technologies.
More information about Oncology Med, Inc. can be found at www.oncologymed.com.
----------------------------------------------------------
As a trader, a very intelligent place to put your money, is where the money is flowing into. These are the kind of trades that you want to get into.
As the saying goes...follow the money!
To see the complete Movers & Shakers Blog go to: http://www.stockwire.com .
About Stockwire:
Stockwire is a company that is pioneering a new way to research companies before you invest them. It's called a Stockumentary. A Stockumentary is a documentary on a publicly traded company. Imagine a Dateline NBC segment, but on a publicly traded company. We are the first company to ever bring this type of quality research to investors in this format.
The Stockumentary has video interviews with management, product demos, video tours of office or factory, research reports, sec filings and much more. All of this is delivered to investors in high quality video, either by mail or email.
Stockwire.com is owned by Stockwire Research Group Inc. (SRGI) and is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies.
As detailed below, this publication accepts compensation from some of the companies from which it features. To the degrees listed herein, this Newsletter should not be regarded as an independent publication. All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the Newsletter is neither an offer nor solicitation to buy or sell any securities mentioned.
While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.
THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF STOCKWIRE RESEARCH GROUP INC..
We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at www.sec.gov and/or the National Association of Securities Dealers ("NASD") at www.nasd.com. The NASD has published information on how to invest carefully at its web site.
Readers can review all public filings by companies at the SEC's EDGAR page. www.sec.gov/edgar.shtml
Stockwire.com is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. Stockwire.com is not a registered investment advisor or broker-dealer. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible.
From time to time SRGI sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.
Moreover, as detailed below, this publication accepts compensation from third party consultants and/or companies which it features on Stockwire.com, which is owned by Stockwire Research Group Inc. (SRGI). To the degrees enumerated herein, this newsletter and website should not be regarded as an independent publication.
All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company on Stockwire.com is neither an offer nor solicitation to buy or sell any securities mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.
THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF STOCKWIRE.COM.
We often accept restricted shares of company stock; by SEC regulations, restricted shares cannot be sold into the market for a period of at least one year from the time that the shares are issued. In such cases, we detail in the Disclaimer the specific term of any restrictions. We also receive compensation in the form of stock options, in which case we receive the right to buy shares of the stock of the company at issue, at a specified time and a specified price. In such circumstances, we specify on our Disclaimer the terms of the options received. On occasion, we also accept free-trading shares in a company that we cover. We intend to sell these shares at any given time.
While our policies as detailed above are designed to minimize any impact upon our members of a conflict of interest between our company and our members, each member should be fully aware that such potential and actual conflicts of interest may well exist due to the compensation structure detailed herein. For this reason, and because the information contained on Stockwire.com is updated on a regular basis as circumstances change, each member is strongly encouraged to periodically review the Profile Compensation section at http://www.stockwire.com/disclaimer_profiles.htm .
The Stockwire Group .
512.358.8440 .
info@stockwire.com .
